Artificial Intelligence (AI) segmentation used in conjunction with LMD to increase discovery throughput.

Biomarker Discovery with Laser Microdissection

Unlock hidden disease mechanisms at the single-cell level—see how spatial proteomics and LMD expose critical targets for tomorrow’s therapies.

Artificial Intelligence (AI) segmentation used in conjunction with LMD to increase discovery throughput. Artificial_Intelligence__AI__segmentation_used_in_conjunction_with_LMD.jpg

Explore the potential of spatial proteomics workflows, such as Deep Visual Proteomics (DVP), to decipher pathology mechanisms and uncover druggable targets.

Altered protein expression, abundance, or activity can significantly impact cellular function—often contributing to disease. Remarkably, the proteome can vary dramatically between neighboring cells. Spatial proteomics accounts for this cellular heterogeneity to reveal pathological mechanisms.

Laser Microdissection (LMD) enables access to single cells for downstream analysis while preserving their spatial context—forming the foundation of spatial proteomics.

What to expect from the poster

  • Learn how to precisely isolate biological material down to the single-cell level—while preserving spatial context
  • Discover cell-resolved proteomic analysis of heterogeneous structures using Deep Visual Proteomics (DVP)
  • Explore evidence showing how spatial proteomic workflows uncover pathology mechanisms and identify druggable targets
  • View illustrations and examples of spatial proteomics workflows
  • Understand how Laser Microdissection enables and enhances each of these insights

Download the Poster

By clicking SUBMIT, I agree to Leica Microsystems GmbH's Terms of Use and Privacy Policy. I understand my privacy choices regarding my personal data as detailed in the Privacy Policy.

Scroll to top